Tag Archives: BIO ETF’s

FED Comments Focus On “Bubble” Stocks In Social Media and Biotech…. Update-1

Update 8PM EDT NASDAQ Holds Losses to 0.54%-Futures Stable Biotech Damage Across the Sector-Rayno Life Science Portfolio Notes Large Caps off about 2% (FBT), but Gilead (GILD) down only 0.95% and Roche (RHHBY) up 0.28%. Rayno Biopharma stocks all red down 3-4% with XBI down 3.86%, IBB down 2.2%. Damage not as severe in Diagnostics […]

Leave a comment Continue Reading →

Snap-Back Rally in Biotech Up 4+% Friday

Life Science Stocks Surge Ahead From February Lows  NASDAQ Up 1.67%, IBB Up 4%, FBIOX up 4.72%, XBI up 5.64%, XLV up 1.7% The soaring biotech sector would not let a losing week go by and took off early Friday erasing most losses for the week 2/3 to 2/7. Institutions can apparently drive biotech stocks […]

Comments Off Continue Reading →

Biotech Rally Update at New Highs: ETFs (IBB,PBE) Beat Five Star Fidelity Fund (FBIOX)

Up until recently the Fidelity Select Biotechnology Fund (FBIOX) has outperformed all ETFs but now the IBB and PBE are leaders over the last 3 months. There have been two recent mini-corrections but over the past two weeks the IBB has soared up almost 15% for the past 3 months.The PBE has also outperformed but the […]

Comments Off Continue Reading →

Biotechnology Bull Market Gets Second Wind To All Time Highs: ALR, GILD, ILMN,

Dow, S&P and Biotech Sector Hit All Time Highs NASDAQ Still 1000+Pts Under 2000 High Levels After a 10% sell-off in early October many large cap biopharmaceutical and diagnostic stocks are at new highs with the major indices at or near their October highs. The bellwether ETF IBB ($211.30) is flat after the index was […]

Comments Off Continue Reading →

Market Sell-Off Accelerating As Shut-Down Drags On Update 10/4 CLDX

Life Science Trading Update 10/4/13       NASDAQ up 0.88% at 3809 Is the market expecting Boehner to settle? Green screen today with most market leaders up  about 2%: AMGN, BIIB, PCYC, REGN, VPHM. ETFs up in the 1% range. DX and Tools Movers: GHDX, ILMN. Mid and small-cap biopharmaceuticals: very strong except notable weakness […]

Comments Off Continue Reading →

Stocks Snap-Back After Sell-Off: NASDAQ Up 0.55%, ASTX Soars

But Uncertainty Clouds Intermediate Term Economic Outlook:  Oil prices, Emerging Markets, Russia and the FED Concerns about another Middle East war and a spike in oil prices waned a bit today but many “undertoads” remain such as weak economic data, taper talk, Q4 earnings and a slowdown in housing. So yesterday’s grim warnings about a […]

Comments Off Continue Reading →